Bacteriophage exploitation of bacterial biofilms: Phage preference for less mature targets?

FEMS Microbiology Letters

Volumn 363, Issue 3, 2015, Pages

  Abedon, Stephen T ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Antibiofilm activity; Biofilm; Ecology; Microcolony; Phage therapy; Phage mediated biocontrol of bacteria

Indexed keywords

ADSORPTION; BACTERIAL CLEARANCE; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL METABOLISM; BACTERIOLYSIS; BACTERIOPHAGE; BACTERIUM COLONY; BIOFILM; MICROBIAL COMMUNITY; NONHUMAN; NOTE; POPULATION GROWTH; PREDATION; PRIORITY JOURNAL; VIRION; VIRUS RELEASE; WOUND INFECTION; BACTERIUM; GROWTH, DEVELOPMENT AND AGING; VIROLOGY;

BACTERIA; BACTERIOPHAGES; BIOFILMS;

EID: 84960124084     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1093/femsle/fnv246     Document Type: Note

References (39)

1. Abedon ST. Bacteriophages and Biofilms: Ecology, Phage Therapy, Plaques. Hauppauge, New York: Nova Science Publishers, 2011.
2. Abedon ST. Spatial vulnerability: bacterial arrangements,microcolonies, and biofilms as responses to low rather than high phage densities. Viruses 2012;4:663-87.
3. Abedon ST. Ecology of anti-biofilm agents I. Antibiotics versus bacteriophages. Pharmaceuticals 2015a;8:525-58.
4. Abedon ST. Ecology of anti-biofilm agents II. Bacteriophage exploitation and biocontrol of biofilm bacteria. Pharmaceuticals 2015b;8:559-89.
5. Azeredo J, Sutherland IW. The use of phages for the removal of infectious biofilms. Curr Pharm Biotechnol 2008;9:261-6.
6. Berngruber TW, Lion S, Gandon S. Spatial structure, transmissionmodes and the evolution of viral exploitation strategies. PLoS Pathog 2015;11:e1004810.
7. Bjarnsholt T. The role of bacterial biofilms in chronic infections. APMIS Suppl 2013;1-51.
8. Briandet R, Lacroix-Gueu P, Renault M et al. Fluorescence correlation spectroscopy to study diffusion and reaction of bacteriophages inside biofilms. Appl Environ Microb 2008;74: 2135-43.
9. Brown MRW, Allison DG, Gilbert G. Resistance of bacterial biofilms to antibiotics: a growth-rate related effect? J Antimicrob Chemoth 1988;22:777-80.
10. Brüssow H. Bacteriophage-host interaction: from splendid isolation into a messy reality. Curr Opin Microbiol 2013;16: 500-6.
11. Chan BK, Abedon ST. Bacteriophages and their enzymes in biofilm control. Curr Pharm Des 2015;21:85-99.
12. Cooper RA, Bjarnsholt T, Alhede M. Biofilms in wounds: a review of present knowledge. J Wound Care 2014;23:570-80.
13. d'Hérelle F, Smith GH. The Bacteriophage and its Clinical Application. Springfield, Illinois: Charles C. Thomas, Publisher, 1930.
14. Diaz-Munoz SL, Koskella B. Bacteria-phage interactions in natural environments. Adv Appl Microbiol 2014;89:135-83.
15. Fan X, LiW, Zheng F et al. Bacteriophage inspired antibiotics discovery against infection involved biofilm. Crit Rev Eukar Gene 2013;23:317-26.
16. Flemming HC,Wingender J. The biofilm matrix. Nat Rev Microbiol 2010;8:623-33.
17. Hadas H, Einav M, Fishov I et al. Bacteriophage T4 development depends on the physiology of its host Escherichia coli. Microbiology 1997;143:179-85.
18. Hall MR, McGillicuddy E, Kaplan LJ. Biofilm: basic principles, pathophysiology, and implications for clinicians. Surg Infect (Larchmt) 2014;15:1-7.
19. Harper DR, Parracho HMR, Walker J et al. Bacteriophages and biofilms. Antibiotics 2014;3:270-84.
20. Heilmann S, Sneppen K, Krishna S. Coexistence of phage and bacteria on the boundary of self-organized refuges. Proc Natl Acad Sci USA 2012;109:12828-33.
21. Hu J, Miyanaga K, Tanji Y. Diffusion properties of bacteriophages through agarose gel membrane. Biotechnol Progr 2010;26:1213-21.
22. Hu J, Miyanaga K, Tanji Y. Diffusion of bacteriophages through artificial biofilm models. Biotechnol Progr 2012;28:319-26.
23. Liu J, Prindle A, Humphries J et al. Metabolic co-dependence gives rise to collective oscillations within biofilms. Nature 2015;523:550-4.
24. Loc-Carrillo C, Wu S, Beck JP. Phage therapy of wounds and related purulent infections. In: Hyman P, Abedon ST (eds). Bacteriophages in Health and Disease. Wallingford, UK: CABI Press, 2012, 185-202.
25. Macia MD, Rojo-Molinero E, Oliver A. Antimicrobial susceptibility testing in biofilm-growing bacteria. Clin Microbiol Infect 2014;20:981-90.
26. Miller RV, Day M. Contribution of lysogeny, pseudolysogeny, and starvation to phage ecology. In: Abedon ST (ed.). Bacteriophage Ecology. Cambridge, UK: Cambridge University Press, 2008, 114-43.
27. Parasion S, Kwiatek M, Gryko R et al. Bacteriophages as an alternative strategy for fighting biofilm development. Pol J Microbiol 2014;63:137-45.
28. Percival SL, McCarty SM, Lipsky B. Biofilms and wounds: an overview of the evidence. Adv Wound Care 2015;4:373-81.
29. Scali C, Kunimoto B. An update on chronic wounds and the role of biofilms. J Cutan Med Surg 2013;17:371-6.
30. Schmerer M, Molineux IJ, Ally D et al. Challenges in predicting the evolutionary maintenance of a phage transgene. J Biol Eng 2014;8:21.
31. Schrag S, Mittler JE. Host-parasite persistence: the role of spatial refuges in stabilizing bacteria-phage interactions.AmNat 1996;148:348-77.
32. Shen Y, MitchellMS, Donovan DMet al. Phage-based enzybiotics. In: Hyman P, Abedon ST (eds). Bacteriophages in Health and Disease. Wallingford, UK: CABI Press, 2012, 217-39.
33. Sillankorva S, Azeredo J. The use of bacteriophages and bacteriophage-derived enzymes for clinically relevant biofilm control. In: Borysowski J, Miedzybrodzki R, Górski A (eds). Phage Therapy: Current Research and Applications. Norfolk, UK: Caister Academic Press, 2014.
34. Ślopek S,Weber-Dabrowska B, Dabrowski M et al. Results of bacteriophage treatment of suppurative bacterial infections in the years 1981-1986. Arch Immunol Ther Ex 1987;35:569-83.
35. Stewart PS, Franklin MJ. Physiological heterogeneity in biofilms. Nat Rev Microbiol 2008;6:199-210.
36. Sutherland IW, Hughes KA, Skillman LC et al. The interaction of phage and biofilms. FEMS Microbiol Lett 2004;232:1-6.
37. Weber-Dabrowska B, Mulczyk M, Górski A. Bacteriophage therapy of bacterial infections: an update of our institute's experience. Arch Immunol Ther Ex 2000;48:547-51.
38. Whitman WB, Coleman DC, Wiebe WJ. Prokaryotes: the unseen majority. Proc Natl Acad Sci USA 1998;95:6578-83.
39. Wilking JN, Angelini TE, Seminara A et al. Biofilms as complex fluids. MRS Bull 2011;36:385-91.